Work Here?
Overview
PetIQ provides a full suite of affordable pet care by owning the development, manufacturing, packaging, and distribution of veterinary products, along with operating veterinary clinics and wellness centers. Its products include flea and tick treatments, health and wellness items, prescription drugs, and pet treats, which are sold through its own channels to owners, clinics, and retailers. The company distinguishes itself by controlling the entire supply chain in-house, enabling consistent quality and lower costs, while combining product delivery with direct veterinary services. PetIQ aims to make high-quality pet care more accessible and affordable and to grow as a leading integrated provider in the veterinary market.
About PetIQ
Industries
Industrial & Manufacturing
Healthcare
Consumer Goods
Company Size
501-1,000
Company Stage
IPO
Headquarters
Eagle, Idaho
Founded
2010
Simplify's Take
What believers are saying
- Bansk Group's $1.5B acquisition closed October 2024, funding product expansion.
- Walmart partnership runs 65+ in-store clinics, capturing retail foot traffic.
- SENTRY Portable Calming Diffuser launched December 2023 boosts behavioral segment.
What critics are saying
- Walmart vertically integrates pet services, ending PetIQ clinic reliance in 12-24 months.
- Chewy Pharmacy expansion undercuts PetIQ's 60,000 retail distribution points.
- Omaha facility concentration halts supply chain on any disruption.
What makes PetIQ unique
- PetIQ's vertical integration controls manufacturing in four U.S. facilities including Omaha.
- PetIQ operates 2,900+ VIP Petcare clinics for convenient wellness services.
- PetIQ brands like SENTRY and Minties target flea, tick, and behavioral wellness.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$1.5B
Above
Industry Average
Funded Over
1 Rounds
Stock Price
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 0%2 year growth
↑ 9%Veterinary Services Market. The global veterinary services market, valued at USD 102.3 billion in 2021, is projected to experience robust growth at a compound annual growth rate (CAGR) of 8.4% from 2022 to 2032. According to industry analysis, market revenue is expected to expand 2.4 times, reaching approximately USD 244.4 billion by 2032. This growth is fueled by an increasing prevalence of zoonotic and food-borne infections, rising demand for emergency veterinary care, and government-led initiatives focused on food security, biosecurity, and animal safety. The COVID-19 pandemic significantly disrupted the cattle industry, leading to temporary closures of processing and packaging plants worldwide. Supply chain challenges also impacted food service businesses, further straining the market
PetIQ, Inc. has secured stockholder approval for a $1.5 billion merger with Bansk Group, with the deal expected to close on October 25, 2024. This merger aims to enhance PetIQ's growth in the pet healthcare sector by leveraging Bansk Group's investment expertise. The merger will provide PetIQ with increased access to capital for product development, marketing, and distribution expansion.
PetIQ, Inc. (NASDAQ: PETQ) will be acquired by Bansk Group in an all-cash deal valued at approximately $1.5 billion. PetIQ stockholders will receive $31.00 per share, a significant premium over the recent trading price of around $10. The acquisition reflects the strategic importance of PetIQ in the pet healthcare market and is expected to boost PetIQ shares as the transaction nears completion.
Bansk Group has agreed to acquire PetIQ, a US-based pet medication, health and wellness company, in a $1.5 billion take-private deal.
PetIQ, Inc. (Nasdaq: PETQ) has entered into a definitive agreement to be acquired by Bansk Group for $31.00 per share in an all-cash transaction valued at approximately $1.5 billion. The deal represents a 41% premium to the 30-day volume-weighted average stock price and a 51% premium to the closing stock price as of August 6, 2024. PetIQ's Board of Directors has approved the agreement, which aims to leverage Bansk Group's expertise in consumer health products to further PetIQ's growth initiatives.
There are no jobs for PetIQ right now.
Find jobs on Simplify and start your career today
About PetIQ
Industries
Industrial & Manufacturing
Healthcare
Consumer Goods
Company Size
501-1,000
Company Stage
IPO
Headquarters
Eagle, Idaho
Founded
2010
There are no jobs for PetIQ right now.
Find jobs on Simplify and start your career today